Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.


Bearish
3
Neutral
6
Bullish
5
Bearish
34
Neutral
6
Bullish
6
Bearish
31
Neutral
0
Bullish
1
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
Get In-depth insights on EPS and Revenue forecasts
No. of Analysts
1Y Price Target
Q3 EPS Estimate
Q3 Revenue Estimate
Price, EPS and Revenue Projections
Strong Buy
3
Buy
2
Hold
2
Sell
0
Strong Sell
0
updated on
Dec 03, 2025

Market Cap
₹ 22,933 Cr
P/E
32.45
Pharmaceuticals
Pharmaceuticals - Multinational
22,933 Cr
Low Risk
32.5
41.4
2.6
6.0
5,987.65
3,742.90
Sales CAGR
1Y
-0.43%
3Y
-4.40%
5Y
1.18%
10Y
0.93%
Profit CAGR
1Y
-11.89%
3Y
7.81%
5Y
8.56%
10Y
14.74%
ROE
TTM
18.36%
3Y
17.63%
5Y
18.76%
10Y
16.42%
ROCE
TTM
24.12%
3Y
23.08%
5Y
24.20%
10Y
22.28%
Performance
STEADY PERFORMER
Valuation
REASONABLE
Growth
STABLE
Profitability
MODERATE MARGIN
Technicals
Bearish
Risk
LOW RISK